MERIDIAN BIOSCIENCE INC (VIVO) [Rocket]

In millions, except per share items	Sep-30-22	Sep-30-21	Sep-30-20	Sep-30-19	Sep-30-18	Sep-30-17	Sep-30-16	Sep-30-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Diagnostics	155.9	127.8	121.1	136.7	150.5	143.5	145.1	146.1
Life Science	177.1	190.1	132.5	64.3	63.1	57.3	51.0	48.7
Total revenues	333.0	317.9	253.7	201.0	213.6	200.8	196.1	194.8
Revenue growth [+]	4.8%	25.3%	26.2%	-5.9%	6.4%	2.4%	0.6%	3.2%
Diagnostics	22.0%	5.5%	-11.4%	-9.2%	4.8%	-1.1%	-0.7%	3.3%
Life Science	-6.8%	43.5%	106.0%	1.9%	10.2%	12.3%	4.6%	2.9%
Cost of goods sold	144.7	116.7	97.4	82.3	82.5	76.5	68.9	72.9
Gross profit	188.4	201.1	156.2	118.7	131.0	124.3	127.2	121.9
Gross margin	56.6%	63.3%	61.6%	59.1%	61.4%	61.9%	64.9%	62.6%
Selling, general and administrative [+]	88.4	76.3	70.8	62.0	69.8	63.5	59.5	53.2
Sales and marketing	31.3	26.8	26.5	28.0	34.0	32.4	30.1	25.6
General and administrative	57.1	49.5	44.3	34.0	35.8	31.1	29.4	27.6
Research and development	24.3	23.9	23.7	17.8	16.6	16.0	14.2	12.6
Other operating expenses	20.1	8.8	6.0
EBITDA [+]	72.0	107.4	69.3	48.9	52.6	52.9	60.2	61.3
EBITDA growth	-33.0%	55.0%	41.7%	-7.0%	-0.6%	-12.1%	-1.8%	5.7%
EBITDA margin	21.6%	33.8%	27.3%	24.3%	24.6%	26.3%	30.7%	31.5%
Depreciation	6.6	6.5	5.8	5.4	4.5	4.3	3.9	3.5
EBITA	65.4	100.9	63.5	43.5	48.1	48.5	56.2	57.8
EBITA margin	19.6%	31.7%	25.0%	21.6%	22.5%	24.2%	28.7%	29.7%
Amortization of intangibles	9.9	8.8	7.7	4.5	3.4	3.8	2.7	1.7
EBIT [+]	55.5	92.1	55.7	38.9	44.6	44.8	53.5	56.1
EBIT growth	-39.8%	65.3%	43.1%	-12.8%	-0.3%	-16.4%	-4.5%	7.0%
EBIT margin	16.7%	29.0%	22.0%	19.4%	20.9%	22.3%	27.3%	28.8%
Non-recurring items [+]	1.1	-0.9	-5.6	6.2	13.1	7.4	2.2
Asset impairment						6.6
Restructuring charges	1.1		0.7	4.6	8.7	0.1	2.2
Legal settlement				1.6	4.3	0.6
Loss on contingent liability		-0.9	-6.3
Interest expense, net [+]	1.2	1.9	2.5	1.3	1.1	1.5	0.8	0.0
Interest expense	1.2	1.9	2.6	1.9	1.5	1.6	0.9
Interest income	0.0		0.1	0.7	0.4	0.2	0.1	0.0
Other income (expense), net [+]	1.1	-0.7	0.5	0.1	-0.1	0.5	0.1	-1.0
Other	7.8	4.6	4.0	3.6	-0.1	0.5	0.1	-1.0
Pre-tax income	54.3	90.5	59.3	31.6	30.4	36.4	50.6	55.1
Income taxes	11.9	19.0	13.1	7.2	6.5	14.9	18.4	19.5
Tax rate	21.8%	21.1%	22.1%	22.7%	21.5%	40.8%	36.4%	35.5%
Net income	42.5	71.4	46.2	24.4	23.8	21.6	32.2	35.5
Net margin	12.7%	22.5%	18.2%	12.1%	11.2%	10.7%	16.4%	18.2%

Basic EPS [+]	$0.97	$1.65	$1.08	$0.57	$0.56	$0.51	$0.77	$0.85
Growth	-41.0%	53.2%	88.2%	1.6%	10.3%	-33.4%	-10.1%	1.8%
Diluted EPS [+]	$0.96	$1.62	$1.07	$0.57	$0.56	$0.51	$0.76	$0.85
Growth	-41.0%	51.7%	88.2%	1.9%	10.2%	-33.4%	-10.1%	2.1%

Dividends per share [+]				$0.25	$0.50	$0.58	$0.80	$0.80
Growth			-100.0%	-50.0%	-13.0%	-28.1%	0.0%	1.3%

Shares outstanding (basic) [+]	43.6	43.3	42.9	42.6	42.3	42.2	42.0	41.7
Growth	0.7%	0.9%	0.7%	0.6%	0.3%	0.4%	0.8%	0.5%
Shares outstanding (diluted) [+]	44.4	44.0	43.2	42.9	42.8	42.6	42.4	42.0
Growth	0.8%	1.9%	0.6%	0.3%	0.4%	0.4%	0.9%	0.2%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.